GlucoTrack
GCTK
3 hedge funds and large institutions have $18.5K invested in GlucoTrack in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
73% less capital invested
Capital invested by funds: $68.9K → $18.5K (-$50.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.89K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boston Financial Management
Boston,
Massachusetts
| $8.97K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $5.62K | +$5.89K | +1 | +50% |
|
|
AF
3
Alerus Financial
Grand Forks,
North Dakota
| $3.91K | – | – | – |
|
GCTK Hedge Fund Activity: Q1 2023 in Review
3 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q1 2023, worth a combined $18.5K — down 73% from $68.9K a quarter earlier.
Fund positioning in GCTK was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $5.89K.
- 3 institutional investors held GlucoTrack (GCTK) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $18.5K of GlucoTrack stock for Q1 2023, down 73% quarter-over-quarter.
- 0 funds opened new GlucoTrack positions in Q1 2023 and 0 closed out.
- The largest GlucoTrack buyer in Q1 2023 was Susquehanna International Group, an estimated $5.89K added.
Based on aggregated 13F filings for Q1 2023.